Integer Holdings (ITGR) Total Non-Current Liabilities (2010 - 2026)
Integer Holdings' (ITGR) quarterly Total Non-Current Liabilities came in at $1.7 billion in Q3 2026, up 2.75% year-over-year from $1.6 billion in Q3 2025, and little changed quarter-over-quarter from $1.7 billion in Q2 2026.
Analysis
Integer Holdings (ITGR) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Integer Holdings has disclosed Total Non-Current Liabilities across 17 years of filings, most recently posting $1.7 billion for Q3 2026.
- In Q3 2026, Total Non-Current Liabilities rose 2.75% year-over-year to $1.7 billion; the TTM figure through Jul 2026 stood at $1.7 billion (up 2.75% YoY), while the FY2025 annual figure was $1.6 billion, up 14.69% from the prior year.
- Total Non-Current Liabilities came in at $1.7 billion for Q3 2026 at Integer Holdings, roughly flat from $1.7 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $1.7 billion in Q2 2026 to a low of $1.2 billion in Q2 2022.
- Average Total Non-Current Liabilities over 5 years is $1.5 billion, with a median of $1.5 billion recorded in 2023.
- Year-over-year, Total Non-Current Liabilities jumped 37.64% in 2022 and decreased 0.02% in 2023.
- Over 5 years, Total Non-Current Liabilities stood at $1.4 billion in 2022, then increased by 3.36% to $1.4 billion in 2023, then gained by 1.71% to $1.4 billion in 2024, then gained by 14.69% to $1.6 billion in 2025, then climbed by 2.69% to $1.7 billion in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $1.7 billion in Q3 2026, $1.7 billion in Q2 2026, and $1.6 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Integer Holdings | 4.29 Bn | 4.27 Bn | 112.94 Mn | 1.69 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 1.69 Bn |
| Apr 3, 2026 | 1.69 Bn |
| Dec 31, 2025 | 1.64 Bn |
| Sep 26, 2025 | 1.63 Bn |
| Jun 27, 2025 | 1.64 Bn |
| Mar 28, 2025 | 1.66 Bn |
| Dec 31, 2024 | 1.43 Bn |
| Sep 27, 2024 | 1.52 Bn |
| Jun 28, 2024 | 1.55 Bn |
| Mar 29, 2024 | 1.57 Bn |
| Dec 31, 2023 | 1.41 Bn |
| Sep 29, 2023 | 1.36 Bn |
| Jun 30, 2023 | 1.40 Bn |
| Mar 31, 2023 | 1.44 Bn |
| Dec 31, 2022 | 1.36 Bn |
| Sep 30, 2022 | 1.36 Bn |
| Jul 1, 2022 | 1.37 Bn |
| Apr 1, 2022 | 1.22 Bn |
| Dec 31, 2021 | 1.21 Bn |
| Oct 1, 2021 | 988.79 Mn |